<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20190520043645N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2020-01-01</date_registration>
      <primary_sponsor>Kerman University of Medical Sciences</primary_sponsor>
      <public_title>Evaluation the impact of psycho education on anxiety, depression and mania in bipolar disorder patients based on mobile application</public_title>
      <acronym></acronym>
      <scientific_title>Evaluation the impact of psycho education on anxiety, depression and mania in bipolar disorder patients based on mobile application</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2018-12-19</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>60</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/39685</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Factorial, Purpose: Education/Guidance, Randomization description: The current  study is a two-group randomized trial with pre-test and post-test design. The method used to randomize the random number table was done by the project partner. As the colleague touches one of the numbers and moves in a predetermined direction, the numbers are recorded and assigned to different groups. Randomization was performed at the first measurement at the individual level. Researchers responsible for collecting data and participants were aware of the group's task after randomization. The researchers who analyzed the data were not aware of the group allocation of participants.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Bipolar affective disorder.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group:  Educational content of the application was extracted from a psychiatric book entitled "Bipolar Disorder and Continuing Life". All extracted information were summarized and rewrite in simple language. The educational content was disused in an  expert panel consisted of  psychiatrists and medical bioinformatic. The 12 main topics of the educational content were pharmaceutical therapy, psychiatry therapy, adolescents, marriage, anxiety management, cognitive bias, irritability, communication skill, focusing on goals, health improvement, definitions of concepts and medications. The application with the name of "Bipolar Disorder and Continuing Life", was designed for the Android operating system in the Android Studio environment using Java language. The 12 main topics of educational content was embedded into the application. Each main menus is subdivided into sub-menus according to the volume and categorization of the contents.To evaluate the initial version of the application several psychiatrists and users were assessed the application. Finally, after troubleshooting, the final version of the application was prepared.The participants were evaluated in two stages. In the first step, when entering the study depression, anxiety, and mania of all participants were measured using Beck Anxiety Inventory, Beck Depression Inventory, and Yankee Mania Rating Scale. After discharge from hospital, the application "Bipolar Disorder and Continuing Life" was installed on the patients' mobile phones. Intervention 2: Control group:After randomization, per-test was conducted one day before starting the intervention. Participants were assessed depression, mania and anxiety as outcome variable. Also, post-test was performed one day after the end of intervention. The "Bipolar disorder and continuing life" application did not provided to the control group and they received routine education after discharge.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is No more information</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Zohreh Hashemi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Haramali Street, next to Astan Quds Razavi, Mashhad</address>
        <city>Mashhad</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>919583134</zip>
        <telephone>+98 51 3711 2701</telephone>
        <email>hzohreh62@gmail.com</email>
        <affiliation>Kerman University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Zohreh Hashemi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Horamali Street, next to Astan Quds Razavi, Mashhad</address>
        <city>Mashhad</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>7616913555</zip>
        <telephone>+98 34 3132 5700</telephone>
        <email>hzohreh62@gmail.com</email>
        <affiliation>Kerman University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Diagnosis of bipolar I or bipolar II disorder according to the criteria in the Diagnostic and Statistical Manual of Mental Disorders, 4th edition (DSM-IV)
Having a compatible smartphone for the 3-month study period
Absence of obvious psychiatric symptoms (euthymic state)
No alcohol or drug abuse up to 6 month prior to the study
No physical illness at the same time
Be literate
Sufficient knowledge of the Persian languag
Adults aged 18 to 60 years</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>60 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Need for inpatient treatment at the time of recruitment, ,
Suicidality
Diagnosis of psychosis ، schizophrenia or an intellectual disability</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>F31</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Bipolar disorder</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Behavior</i_code>
      <i_code>N/A</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group:  Educational content of the application was extracted from a psychiatric book entitled "Bipolar Disorder and Continuing Life". All extracted information were summarized and rewrite in simple language. The educational content was disused in an  expert panel consisted of  psychiatrists and medical bioinformatic. The 12 main topics of the educational content were pharmaceutical therapy, psychiatry therapy, adolescents, marriage, anxiety management, cognitive bias, irritability, communication skill, focusing on goals, health improvement, definitions of concepts and medications. The application with the name of "Bipolar Disorder and Continuing Life", was designed for the Android operating system in the Android Studio environment using Java language. The 12 main topics of educational content was embedded into the application. Each main menus is subdivided into sub-menus according to the volume and categorization of the contents.To evaluate the initial version of the application several psychiatrists and users were assessed the application. Finally, after troubleshooting, the final version of the application was prepared.The participants were evaluated in two stages. In the first step, when entering the study depression, anxiety, and mania of all participants were measured using Beck Anxiety Inventory, Beck Depression Inventory, and Yankee Mania Rating Scale. After discharge from hospital, the application "Bipolar Disorder and Continuing Life" was installed on the patients' mobile phones.</i_keyword>
      <i_keyword>Control group:After randomization, per-test was conducted one day before starting the intervention. Participants were assessed depression, mania and anxiety as outcome variable. Also, post-test was performed one day after the end of intervention. The "Bipolar disorder and continuing life" application did not provided to the control group and they received routine education after discharge.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Depression Score in Beck Questionnaire. Timepoint: Three months. Method of measurement: Beck Depression Inventory.</prim_outcome>
      <prim_outcome>Anxiety Score in Beck's Inventory. Timepoint: Three months. Method of measurement: Beck Anxiety Inventory.</prim_outcome>
      <prim_outcome>Mania score in Young Mania Rating Scale. Timepoint: Three months. Method of measurement: Young Mania Rating Scale.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>1. Timepoint: 1. Method of measurement: 1.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Kerman University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2018-07-21</approval_date>
        <contact_name>Ethics Committee of Kerman University of Medical Sciences</contact_name>
        <contact_address>The first center of Seven Alavi Gardens, Campus of Medical Sciences ,Kerman Kerman Kerman Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
